Synlogic Announces Third Quarter 2020 Conference Call & Webcast

Synlogic Presents Preclinical Data on SYNB8802 for Enteric Hyperoxaluria at American Society of Nephrology (ASN) Kidney Week 2020

Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer

Synlogic to Present at Upcoming Virtual Banking Conferences

Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update

Synlogic to Present at Upcoming Virtual Banking Conferences

Synlogic Announces Promotion of Antoine 'Tony' Awad to Chief Operating Officer and Additions to Leadership Team

Synlogic Announces Second Quarter 2020 Conference Call & Webcast

Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors

Synlogic Hosts First Virtual R&D Event

Synlogic to Host Virtual R&D Event

Synlogic Announces Termination of AbbVie Collaboration Agreement